Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically

Lauren Jacobson1, Tasneem Ansari, Owen P McGuinness

  • 1Center for Neuropharmacology and Neuroscience, Albany Medical College, MC-136, Albany, NY 12208, USA. JACOBSL@mail.amc.edu

Insights

Repeated hypoglycemia in mice impairs counterregulatory hormone responses, mimicking human counterregulatory failure. This study establishes a new model for investigating defective glucose homeostasis in diabetes mellitus.

Area of Science:

  • Endocrinology
  • Metabolism
  • Diabetes Research

Background:

  • Hypoglycemia-induced counterregulatory failure is a serious complication of insulin therapy for diabetes mellitus.
  • Understanding defective counterregulation requires controlled studies, ideally in models that allow genetic manipulation.
  • Stress influences glucose homeostasis and counterregulatory hormones, necessitating methods to minimize stress in study models.

Purpose of the Study:

  • To develop and validate a model of controlled, repeated hypoglycemia in conscious, unrestrained mice.
  • To investigate the impact of acute and repeated hypoglycemia on counterregulatory hormone responses (epinephrine, corticosterone, glucagon).
  • To assess whether repeated hypoglycemia leads to impaired counterregulatory responses, modeling human counterregulatory failure.

Main Methods:

  • Developed a glucose clamp technique with remote blood sampling in chronically cannulated, conscious, unrestrained male C57BL/6 mice.
  • Subjected mice to two hyperinsulinemic glucose clamps 24 hours apart, with day 1 involving either euglycemia or hypoglycemia, and day 2 involving hypoglycemia for all mice.
  • Measured plasma glucose, insulin, epinephrine, corticosterone, and glucagon levels during the clamps.

Main Results:

  • Hypoglycemia (approx. 80 mg/dl) significantly increased plasma epinephrine, corticosterone, and glucagon compared to euglycemia.
  • Mice subjected to hypoglycemia on day 1 showed significantly higher glucose requirements and lower plasma glucagon and corticosterone on day 2 compared to euglycemic controls.
  • Repeated hypoglycemia tended to decrease plasma epinephrine, though not significantly, suggesting an adaptive or suppressive effect.

Conclusions:

  • The developed model in unrestrained, cannulated mice effectively reproduces human counterregulatory responses to acute and repeated hypoglycemia.
  • Repeated hypoglycemia in this mouse model leads to impaired counterregulatory hormone release, establishing it as a valuable tool for studying counterregulatory failure in diabetes mellitus.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...